胰腺神经内分泌肿瘤（PNETs）的管理极具挑战性，其治疗方案需高度个体化。研究人员围绕 PNETs 的手术管理展开研究，综合分析多项研究成果。结果显示不同大小、功能的 PNETs 手术策略不同。这为临床治疗提供了重要依据，助力优化治疗方案。 在医学领域 ...

Two distinct subtypes discovered, each with dramatically different risks of recurrence Patients with more aggressive subtype can be monitored vigilantly for recurrence and possible treatment, while ...

根治性手术是可切除胰腺神经内分泌肿瘤（pNETs）的标准治疗方法，但淋巴结清扫的必要性和范围仍存在争议。本研究旨在根据转移发生率确定最佳的淋巴结清扫范围。 方法 对复旦大学上海癌症中心治疗的955名患者进行了回顾性分析，其中455名患者接受了淋巴结 ...

SEATTLE -- Surgery for pancreatic neuroendocrine tumors (pNETs) significantly improved survival for all patients except those with the earliest-stage disease, a retrospective review of 4,700 patients ...

Effect of BPM 31510 on survival outcomes when used in combination with gemcitabine in a preclinical model of pancreatic cancer. Serum levels of macrophage inhibitory cytokine-1 (MIC1) and matrix ...

Treatment options for pancreatic neuroendocrine tumors (PNETs) have expanded considerably based on data from pivotal trials such as RADIANT-3 (NCT00510068), 1 Study A6181111 (NCT0 ...

Neuroendocrine tumors (NETs) are rare cancers that can arise in a number of different organs, particularly the gastrointestinal tract, lungs, and pancreas. The clinical course of these tumors can vary ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SEATTLE -- ...

A group of researchers funded by Neuroendocrine Tumor Research Foundation (NETRF) has discovered molecular information that may help predict recurrence of non-functional pancreatic neuroendocrine ...

Survival trends in chemorefractory unresectable intrahepatic cholangiocarcinoma (ICC) and the effect of yttrium-90 (Y90) radioembolization: SEER versus tertiary cancer center. Second-line gemcitabine ...